IsoPlexis Stock

isoplexis.comHealthcareFounded: 2013Funding to Date: $161.52MM

IsoPlexis is building solutions to accelerate the development of curative medicines and personalized therapeutics.

Register for Details

For more details on financing and valuation for IsoPlexis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for IsoPlexis.

Register Today

Other companies like IsoPlexis in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

The newly public provider of single-cell analysis technologies said that the reorganization would help extend its cash runway into the second half of 2024.
The firm is expanding beyond single-cell proteomics with new data types that could help it move into research areas outside its traditional immune profiling focus.